{"log_id": 8188845157203972379, "direction": 0, "words_result_num": 76, "words_result": [{"probability": {"variance": 0.001971, "average": 0.976138, "min": 0.827977}, "location": {"width": 423, "top": 160, "height": 32, "left": 163}, "words": "()利福平单剂量来米特和多剂量利福平联合使用"}, {"probability": {"variance": 0.006123, "average": 0.968114, "min": 0.603654}, "location": {"width": 455, "top": 154, "height": 29, "left": 643}, "words": "浓度较单独使用来氟米特升高约40%),由于随着利福平的"}, {"probability": {"variance": 0.003991, "average": 0.976518, "min": 0.743415}, "location": {"width": 461, "top": 185, "height": 29, "left": 119}, "words": "使用,M1浓度可能继续升高,因此当两药合用时,应慎重"}, {"probability": {"variance": 1e-06, "average": 0.999258, "min": 0.997787}, "location": {"width": 86, "top": 215, "height": 20, "left": 133}, "words": "药物过量】"}, {"probability": {"variance": 0.005956, "average": 0.98156, "min": 0.524253}, "location": {"width": 663, "top": 223, "height": 36, "left": 160}, "words": "据文献报道,如果剂量过大或出现毒性时,可给予考来烯胺或活性炭加以消除。方法"}, {"probability": {"variance": 0.002862, "average": 0.984062, "min": 0.637951}, "location": {"width": 725, "top": 245, "height": 36, "left": 160}, "words": "()口服考来烯胺(8g,3次/24小时),24小时内M1血浆浓度降低约40%,48小时内降低大约"}, {"probability": {"variance": 0.008393, "average": 0.949469, "min": 0.729122}, "location": {"width": 118, "top": 244, "height": 22, "left": 974}, "words": "连续服用11天"}, {"probability": {"variance": 0.01018, "average": 0.958549, "min": 0.606137}, "location": {"width": 285, "top": 278, "height": 23, "left": 122}, "words": "M1血浆浓度可降至0.02μg/ml以下"}, {"probability": {"variance": 0.006296, "average": 0.981796, "min": 0.430505}, "location": {"width": 942, "top": 287, "height": 37, "left": 159}, "words": "()通过胃管或口服给予活性炭(混悬液),每6小时50克,24小时内M血浆浓度降低37%,48小时降低48%。如果临床"}, {"probability": {"variance": 6e-06, "average": 0.998033, "min": 0.99262}, "location": {"width": 249, "top": 321, "height": 23, "left": 119}, "words": "上需要,这些措施可以重复使用"}, {"probability": {"variance": 0.002822, "average": 0.983105, "min": 0.725004}, "location": {"width": 973, "top": 331, "height": 38, "left": 125}, "words": "【临床试验】国内来氟米特治疗狼疮性肾炎Ⅲ期临床试验,采用多中心、随机、平行对照临床研究。共入组患者184例,其中"}, {"probability": {"variance": 0.007393, "average": 0.955521, "min": 0.690346}, "location": {"width": 381, "top": 362, "height": 30, "left": 122}, "words": "试验组(来氟米特)108例,对照组(环磷酰胺)76例"}, {"probability": {"variance": 0.011199, "average": 0.952423, "min": 0.471148}, "location": {"width": 940, "top": 375, "height": 38, "left": 158}, "words": "患者入组标准:年龄18-65岁;狼疮性肾炎肾活检病理类型为I1、IV或伴V型;病情有活动性, SLEDAI狼疮活动积分≥"}, {"probability": {"variance": 0.006485, "average": 0.972543, "min": 0.498749}, "location": {"width": 604, "top": 402, "height": 34, "left": 131}, "words": "分;特续性蛋白尿(≥1g/24h)、镜下血尿;3个月内未用过CTX等细胞毒药物"}, {"probability": {"variance": 0.012967, "average": 0.961435, "min": 0.530507}, "location": {"width": 435, "top": 426, "height": 31, "left": 159}, "words": "治疗方案:试验组:口服来氟米特片,试验开始3天0"}, {"probability": {"variance": 0.007064, "average": 0.953534, "min": 0.645812}, "location": {"width": 447, "top": 421, "height": 29, "left": 651}, "words": "Kg日,以后20-40mg/日维持。对照组:静脉注射环磷酰"}, {"probability": {"variance": 0.010164, "average": 0.957569, "min": 0.418243}, "location": {"width": 775, "top": 446, "height": 33, "left": 117}, "words": "胺,剂量为0.8-1.0/月,每月1次。联合激素:口服强的松,剂量0.8mgKg/日(般在40-60mg/日)"}, {"probability": {"variance": 0.001627, "average": 0.982563, "min": 0.851959}, "location": {"width": 153, "top": 447, "height": 19, "left": 928}, "words": "个月后改为0.5mg/K"}, {"probability": {"variance": 0.001558, "average": 0.977536, "min": 0.832984}, "location": {"width": 555, "top": 469, "height": 34, "left": 115}, "words": "日,然后逐渐减量(每2周减2.5-5mg)至维持量510mg/日。疗程6个月"}, {"probability": {"variance": 0.002869, "average": 0.982365, "min": 0.691945}, "location": {"width": 935, "top": 487, "height": 35, "left": 156}, "words": "疗效判定标准:完全缓解:24小时尿蛋白定量小于0.3g,且尿沉渣(RBC<5HP,WBC<5/HP)、血清白蛋白、血清SC"}, {"probability": {"variance": 0.000102, "average": 0.994828, "min": 0.939576}, "location": {"width": 965, "top": 508, "height": 37, "left": 116}, "words": "及CCr检测均正常。部分缓解:24小时尿蛋白定量介于0.3-3g之间,且下降≥50%,且血清白蛋白≥30g/L,且肾功能稳定"}, {"probability": {"variance": 0.000132, "average": 0.996258, "min": 0.952053}, "location": {"width": 266, "top": 541, "height": 26, "left": 123}, "words": "台疗失败:24小时尿蛋白定量下降"}, {"probability": {"variance": 0.000222, "average": 0.992849, "min": 0.92338}, "location": {"width": 644, "top": 533, "height": 29, "left": 454}, "words": "或24小时尿蛋白定量介于0.3-3g之间,但血清白蛋白<30g/L;或血清SCr上升及"}, {"probability": {"variance": 0.000143, "average": 0.993892, "min": 0.959098}, "location": {"width": 238, "top": 565, "height": 22, "left": 122}, "words": "Cr下降幅度超过基础值的15"}, {"probability": {"variance": 5e-06, "average": 0.997594, "min": 0.995321}, "location": {"width": 39, "top": 587, "height": 20, "left": 154}, "words": "疗效"}, {"probability": {"variance": 0.006157, "average": 0.969803, "min": 0.511557}, "location": {"width": 936, "top": 595, "height": 38, "left": 154}, "words": "综合疗效评价:治疗6个月后,试验组完全缓解22.22%,分缓解59.60%:对照组分别为18.84%,62.32%:治疗6个月"}, {"probability": {"variance": 0.002471, "average": 0.987946, "min": 0.63725}, "location": {"width": 960, "top": 619, "height": 34, "left": 116}, "words": "同基线水平相比,试验组和对照组均能显著降低 SLEDAI评分、降低24小时尿蛋白、提高血清白蛋白、降低SCr、提高C3"}, {"probability": {"variance": 0.004444, "average": 0.972321, "min": 0.769074}, "location": {"width": 163, "top": 650, "height": 24, "left": 113}, "words": "降低ds-DNA阳性率"}, {"probability": {"variance": 0.014388, "average": 0.963915, "min": 0.381758}, "location": {"width": 940, "top": 661, "height": 35, "left": 156}, "words": "试验入组病例活检的病理类型为狼疮肾炎的Ⅲ型、IV、或伴有V型。其中试验组15例病例在治疗6个月后进行了重复肾"}, {"probability": {"variance": 0.011785, "average": 0.958108, "min": 0.483558}, "location": {"width": 984, "top": 684, "height": 35, "left": 111}, "words": "活检。结果显示,经来氟米特治疗后,13例患者狼疮肾炎的活动性降低,急性活动指数下降。其中,7例患者治疗前为I1、IV"}, {"probability": {"variance": 0.017036, "average": 0.961662, "min": 0.363223}, "location": {"width": 431, "top": 712, "height": 30, "left": 112}, "words": "型,经来氟米特治疗后全部转变为病理类型较轻的型"}, {"probability": {"variance": 0, "average": 0.999969, "min": 0.999931}, "location": {"width": 75, "top": 741, "height": 20, "left": 152}, "words": "不良反应"}, {"probability": {"variance": 0.005828, "average": 0.974011, "min": 0.63768}, "location": {"width": 944, "top": 750, "height": 35, "left": 153}, "words": "与药物可能有关/有关的不良反应发生率,试验组为39.81%,对照组为55.26%。试验红发生率≥3%的不良事件包括:脱"}, {"probability": {"variance": 0.001542, "average": 0.990416, "min": 0.72566}, "location": {"width": 987, "top": 773, "height": 35, "left": 109}, "words": "发、血压升高、带状疱疹、转氨酶升高、腹泻/稀便、白细胞下降、皮疹、月经不调、心悸、腹痛;发生率<3%的不良事件包"}, {"probability": {"variance": 2.2e-05, "average": 0.997566, "min": 0.979063}, "location": {"width": 986, "top": 794, "height": 35, "left": 109}, "words": "括:恶心呕吐、上呼吸道感染、血小板下降、乏力、胃烧灼感、厌食、发热、牙周疼痛、视觉异常、尿路感染、咽痛、巨细胞"}, {"probability": {"variance": 0.000341, "average": 0.99496, "min": 0.918875}, "location": {"width": 325, "top": 822, "height": 30, "left": 108}, "words": "病毒感染、体重下降、多毛、肺部感染等"}, {"probability": {"variance": 0.013844, "average": 0.954496, "min": 0.383928}, "location": {"width": 959, "top": 834, "height": 40, "left": 138}, "words": "Ⅲ期临床试验结束后,试验组52例患者自愿继续服用快物,药剂量为10-30mg日:治疗9个月后,90%的患者服药"}, {"probability": {"variance": 0.012562, "average": 0.939339, "min": 0.467795}, "location": {"width": 523, "top": 864, "height": 31, "left": 109}, "words": "剂量减为10-20mg/日。平均随访时间32.7±18.2月,最长观家间"}, {"probability": {"variance": 0.001197, "average": 0.987579, "min": 0.841421}, "location": {"width": 360, "top": 862, "height": 23, "left": 722}, "words": "治疗6个月时,52例患者完全缓解率为36.5%"}, {"probability": {"variance": 0.011793, "average": 0.946965, "min": 0.605103}, "location": {"width": 527, "top": 884, "height": 35, "left": 110}, "words": "部分缓解率为442%;经过7-72个月的继续治疗完全缓解率为S9"}, {"probability": {"variance": 0.002012, "average": 0.985848, "min": 0.791548}, "location": {"width": 407, "top": 886, "height": 21, "left": 687}, "words": "平分缓解率为30.6%。临床观察期间,共有12人发生"}, {"probability": {"variance": 0.005043, "average": 0.979457, "min": 0.521757}, "location": {"width": 986, "top": 905, "height": 36, "left": 111}, "words": "与试验药物可能有关有关的不良反应,发生率为2308%发生率≥3%的不良事件包括:白细胞下降、转氨酶升高、血小板减"}, {"probability": {"variance": 0.006937, "average": 0.974921, "min": 0.608466}, "location": {"width": 709, "top": 922, "height": 54, "left": 108}, "words": "少发生率<3%的不良事件包括:上呼吸道感染家带状疱疹、尿路感染"}, {"probability": {"variance": 0.000268, "average": 0.990592, "min": 0.954264}, "location": {"width": 93, "top": 959, "height": 20, "left": 113}, "words": "【药理毒理】"}, {"probability": {"variance": 0.023926, "average": 0.945401, "min": 0.375371}, "location": {"width": 949, "top": 969, "height": 37, "left": 146}, "words": "本品为一个具有抗增殖活性的异嗯唑类免疫抑和,作用机理主是抑制二氢乳清酸脱氢酶的活性,从而影响活化淋巴"}, {"probability": {"variance": 0.002911, "average": 0.986205, "min": 0.733471}, "location": {"width": 416, "top": 994, "height": 34, "left": 107}, "words": "细胞的嘧啶合成。体内外试验表明本品具有抗炎作用"}, {"probability": {"variance": 0.000626, "average": 0.986604, "min": 0.875435}, "location": {"width": 483, "top": 995, "height": 24, "left": 575}, "words": "米特的体内活性主要通过其活性代谢产物A771726(M1)而产生"}, {"probability": {"variance": 0.037303, "average": 0.915661, "min": 0.373462}, "location": {"width": 530, "top": 1015, "height": 58, "left": 149}, "words": "本品口服吸收迅速,在胃肠粘膜与肝中迅速转变为活5979"}, {"probability": {"variance": 6e-06, "average": 0.998491, "min": 0.992794}, "location": {"width": 112, "top": 1026, "height": 20, "left": 112}, "words": "【药代动力学】"}, {"probability": {"variance": 0.00092, "average": 0.991078, "min": 0.832177}, "location": {"width": 390, "top": 1038, "height": 25, "left": 700}, "words": "76(M1),口服后6-12小时内A771726的血药浓度"}, {"probability": {"variance": 0.001142, "average": 0.987186, "min": 0.805474}, "location": {"width": 987, "top": 1059, "height": 33, "left": 103}, "words": "达峰值,口服生物利用度(F)约80%,吸收不受高脂肪饮食影响。单次口服50mg或100mg后24小时,血浆A771726浓度分别"}, {"probability": {"variance": 0.009483, "average": 0.967033, "min": 0.421292}, "location": {"width": 988, "top": 1081, "height": 35, "left": 105}, "words": "为4μg/m或8.5μg/mlA771726主要分布于肝、肾和皮肤组织,而脑组织分布较少;A771726血浆浓度较低,血浆蛋白结合率"}, {"probability": {"variance": 0.00452, "average": 0.977102, "min": 0.654743}, "location": {"width": 855, "top": 1103, "height": 33, "left": 109}, "words": "大于99%,稳态分布容积为0.13L/Kg。A771726在体内进一步代谢,并从肾脏与胆汁排泄,其半衰期约10天"}, {"probability": {"variance": 0.003539, "average": 0.982905, "min": 0.760396}, "location": {"width": 276, "top": 1131, "height": 26, "left": 117}, "words": "贮藏】避光,密封,于干燥处保存"}, {"probability": {"variance": 0, "average": 0.999409, "min": 0.998918}, "location": {"width": 41, "top": 1156, "height": 21, "left": 125}, "words": "包装】"}, {"probability": {"variance": 0.010047, "average": 0.952122, "min": 0.495208}, "location": {"width": 826, "top": 1145, "height": 33, "left": 258}, "words": "复合铝箔包装,10片/板×1板/盒;10片/板×2板/盒;8片/板×2板/盒:8片/板×4板/盒;8片/板×6板/盒"}, {"probability": {"variance": 0.007453, "average": 0.955831, "min": 0.647789}, "location": {"width": 564, "top": 1169, "height": 35, "left": 233}, "words": "ng复合铝箔包装,10片/板×1板/盒;10片/板x2板/盒:8片/板×2板/盒"}, {"probability": {"variance": 0.000214, "average": 0.991341, "min": 0.940047}, "location": {"width": 386, "top": 1195, "height": 29, "left": 110}, "words": "【有效期】(1)10mg36个月(2)20mg24个月"}, {"probability": {"variance": 8e-06, "average": 0.998795, "min": 0.987652}, "location": {"width": 307, "top": 1215, "height": 31, "left": 117}, "words": "执行标准】《中国药典》2010年版二部"}, {"probability": {"variance": 0.000401, "average": 0.987303, "min": 0.943629}, "location": {"width": 116, "top": 1245, "height": 19, "left": 114}, "words": "【批准文号】(1)"}, {"probability": {"variance": 0.000187, "average": 0.990609, "min": 0.963831}, "location": {"width": 92, "top": 1241, "height": 19, "left": 290}, "words": "国药准字H"}, {"probability": {"variance": 0.003512, "average": 0.964329, "min": 0.861685}, "location": {"width": 67, "top": 1241, "height": 17, "left": 435}, "words": "50(2"}, {"probability": {"variance": 0.002277, "average": 0.976426, "min": 0.815011}, "location": {"width": 158, "top": 1236, "height": 21, "left": 568}, "words": "国药准字H20050129"}, {"probability": {"variance": 0, "average": 0.999845, "min": 0.9995}, "location": {"width": 76, "top": 1266, "height": 19, "left": 121}, "words": "生产企业"}, {"probability": {"variance": 0.004289, "average": 0.982847, "min": 0.712926}, "location": {"width": 313, "top": 1284, "height": 24, "left": 142}, "words": "企业名称:苏州长征-欣凯制药有限公司"}, {"probability": {"variance": 7e-06, "average": 0.998849, "min": 0.987016}, "location": {"width": 505, "top": 1303, "height": 31, "left": 143}, "words": "生产地址:江苏省苏州吴中经济开发区河东工业园六丰路567号"}, {"probability": {"variance": 0.000292, "average": 0.989647, "min": 0.946626}, "location": {"width": 143, "top": 1335, "height": 20, "left": 140}, "words": "邮政编码:215124"}, {"probability": {"variance": 0.001156, "average": 0.980759, "min": 0.879818}, "location": {"width": 207, "top": 1356, "height": 24, "left": 140}, "words": "电话号码:0512-66981100"}, {"probability": {"variance": 0.003287, "average": 0.970742, "min": 0.803581}, "location": {"width": 200, "top": 1381, "height": 21, "left": 139}, "words": "传真号码:0512-6698073"}, {"probability": {"variance": 0.00054, "average": 0.986824, "min": 0.940482}, "location": {"width": 109, "top": 1405, "height": 19, "left": 139}, "words": "网址:ht"}, {"probability": {"variance": 0.000118, "average": 0.994285, "min": 0.967547}, "location": {"width": 203, "top": 1443, "height": 25, "left": 138}, "words": "美国欣凯公司研制"}, {"probability": {"variance": 0.000149, "average": 0.995284, "min": 0.949326}, "location": {"width": 299, "top": 1462, "height": 29, "left": 137}, "words": "地址:上海浦东张江李冰路67弄3号"}, {"probability": {"variance": 0.025787, "average": 0.889748, "min": 0.486649}, "location": {"width": 158, "top": 1491, "height": 19, "left": 138}, "words": "网址:http://www.cin"}, {"probability": {"variance": 6.2e-05, "average": 0.994053, "min": 0.978553}, "location": {"width": 88, "top": 1485, "height": 21, "left": 425}, "words": "信箱:ck"}, {"probability": {"variance": 0.006335, "average": 0.966647, "min": 0.665164}, "location": {"width": 269, "top": 1509, "height": 24, "left": 137}, "words": "患者免费咨询电话:800-820-5615"}, {"probability": {"variance": 0.008993, "average": 0.93113, "min": 0.702391}, "location": {"width": 90, "top": 1682, "height": 23, "left": 545}, "words": "第-2-1-2-页"}], "language": 3}